JP2013515270A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515270A5
JP2013515270A5 JP2012546198A JP2012546198A JP2013515270A5 JP 2013515270 A5 JP2013515270 A5 JP 2013515270A5 JP 2012546198 A JP2012546198 A JP 2012546198A JP 2012546198 A JP2012546198 A JP 2012546198A JP 2013515270 A5 JP2013515270 A5 JP 2013515270A5
Authority
JP
Japan
Prior art keywords
sample
acid
cancer
cancerous
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515270A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061811 external-priority patent/WO2011087845A2/en
Publication of JP2013515270A publication Critical patent/JP2013515270A/ja
Publication of JP2013515270A5 publication Critical patent/JP2013515270A5/ja
Pending legal-status Critical Current

Links

JP2012546198A 2009-12-22 2010-12-22 前立腺癌の代謝学的プロファイリング Pending JP2013515270A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28920609P 2009-12-22 2009-12-22
US61/289,206 2009-12-22
PCT/US2010/061811 WO2011087845A2 (en) 2009-12-22 2010-12-22 Metabolomic profiling of prostate cancer

Publications (2)

Publication Number Publication Date
JP2013515270A JP2013515270A (ja) 2013-05-02
JP2013515270A5 true JP2013515270A5 (enExample) 2014-01-23

Family

ID=44151645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546198A Pending JP2013515270A (ja) 2009-12-22 2010-12-22 前立腺癌の代謝学的プロファイリング

Country Status (5)

Country Link
US (2) US20110151497A1 (enExample)
EP (1) EP2517022A4 (enExample)
JP (1) JP2013515270A (enExample)
CN (1) CN102893157A (enExample)
WO (1) WO2011087845A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3812009A1 (en) * 2012-02-23 2021-04-28 Keio University Combined anticancer drug sensitivity-determining marker
KR101462206B1 (ko) * 2013-06-26 2014-11-20 한국과학기술연구원 트립토판 대사 변화를 이용한 위암 진단용 기초 정보 제공 방법
JP6222629B2 (ja) * 2013-08-29 2017-11-01 花王株式会社 排尿障害のバイオマーカー
KR101955430B1 (ko) * 2013-10-11 2019-03-11 주식회사 씨스퀘어 사르코신 대사산물 중 과산화물을 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단에 필요한 정보를 제공하는 방법
BR112017004773B1 (pt) * 2014-09-10 2024-02-27 Fundação Pio Xii Hospital De Câncer De Barretos Cnpj/Mf Biomarcadores para avaliação do câncer de mama
CN115236166A (zh) * 2016-05-29 2022-10-25 深圳市绘云生物科技有限公司 肝病相关生物标志物和其使用方法
WO2017213246A1 (ja) * 2016-06-10 2017-12-14 株式会社日立製作所 尿中代謝物による疾病診断法
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
CN106770873B (zh) * 2017-01-19 2019-02-19 中国人民解放军第四军医大学 一种膀胱癌诊断标志物及其应用和诊断试剂盒
CN108344830B (zh) * 2017-01-22 2020-10-16 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒
KR102077058B1 (ko) * 2017-09-21 2020-02-13 연세대학교 산학협력단 대사체 프로파일링을 이용한 유방암의 예후 또는 위험도를 평가하는 방법 및 키트
CN108414661B (zh) * 2018-03-13 2020-04-21 中国医科大学 一种检测生物样品中氨含量的衍生化气相色谱-质谱方法
EP3803390B1 (en) * 2018-06-01 2024-05-01 Lewis, Ian Andrew Method for detecting urinary tract infections and sample analysis
IT201800007264A1 (it) * 2018-07-17 2020-01-17 Metodo per la diagnosi in vitro di carcinoma della prostata mediante biomarcatori urinari
KR102405789B1 (ko) * 2018-08-24 2022-06-07 고려대학교 세종산학협력단 키누레닌 경로 대사체를 포함하는 전립선암 진단용 바이오마커 조성물
EP3629021A1 (en) * 2018-09-26 2020-04-01 Euroimmun Medizinische Labordiagnostika AG Diagnosis of a neuroautoimmune disease
KR20210030883A (ko) * 2019-09-10 2021-03-18 고려대학교 세종산학협력단 인돌아민 2,3-이산소화 효소를 포함하는 전립선암 진단용 마커
US20210333280A1 (en) * 2020-04-23 2021-10-28 YatHing Biotechnology Company Limited Methods related to the diagnosis of prostate cancer
US20230384316A1 (en) * 2020-10-20 2023-11-30 Baylor College Of Medicine Multiplex metabolic markers in plasma for early detection of african american prostate cancer
WO2022149487A1 (ja) * 2021-01-07 2022-07-14 住友化学株式会社 前立腺がんの罹患の可能性を検査する方法
CN114324674A (zh) * 2022-01-21 2022-04-12 苏州南医大创新中心 一种精液中与无精子症有关的分子标志物及其检测方法和应用
CN114487217B (zh) * 2022-02-14 2024-06-25 广州市番禺区中心医院 一种区分前列腺癌和良性前列腺增生的标志物及试剂盒
CN114544812B (zh) * 2022-02-18 2023-06-30 复旦大学附属中山医院 一种代谢组合式标志物在诊断哮喘中的应用
CN116465920B (zh) * 2023-04-03 2023-11-10 汕头大学医学院 用于诊断食管癌的代谢标志物
CN116106535B (zh) * 2023-04-11 2023-08-11 南京品生医学检验实验室有限公司 生物标志物组合在制备乳腺癌预测产品中的应用
TW202528739A (zh) * 2023-09-05 2025-07-16 國立臺灣大學 用於前列腺癌的生物標記
DE102023125870A1 (de) * 2023-09-25 2025-03-27 Numares Ag Verwendung eines Markersets für die Diagnostik des Prostatakarzinoms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020139A (en) * 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US6866837B2 (en) * 1998-06-05 2005-03-15 Mallinckrodt Inc. Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
WO2001078652A2 (en) * 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20050181375A1 (en) * 2003-01-10 2005-08-18 Natasha Aziz Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
US20070078093A1 (en) * 2003-10-16 2007-04-05 The Administrators Of The Tulane Educational Fund Methods and compositions for treating cancer
US20070055456A1 (en) * 2005-08-31 2007-03-08 Daniel Raftery NMR method for differentiating complex mixtures
WO2007066216A2 (en) * 2005-12-09 2007-06-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fatty acids profile correlated to the propensity or risk of breast cancer
CN101454331A (zh) * 2006-03-24 2009-06-10 菲诺梅诺米发现公司 有效用于诊断前列腺癌的生物标记,及其方法
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
EP2061899B1 (en) * 2006-09-19 2012-08-29 Metabolon Inc. Biomarkers for prostate cancer and methods using the same
US20090047269A1 (en) * 2007-08-16 2009-02-19 The Regents Of The University Of Michigan Metabolomic cancer targets

Similar Documents

Publication Publication Date Title
JP2013515270A5 (enExample)
Sun et al. Electrochemical dual-aptamer-based biosensor for nonenzymatic detection of cardiac troponin I by nanohybrid electrocatalysts labeling combined with DNA nanotetrahedron structure
Mittal et al. Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies
CN110057901B (zh) 拭子和活检样品的快速蒸发电离质谱和解吸电喷雾电离质谱分析
EP3206034A3 (en) Use of fatty acids in methods for detecting cancer
JP2014144959A5 (enExample)
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
CA2815892C (en) Analytical methods and arrays for use in the same
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
BR112013009008A2 (pt) métodos e kits para a detecção de células circulantes de tumor em pacientes pancreáticos com o uso de reagentes de detecção de captura e de coquetel poliespecíficos
CN106066324B (zh) 一种电致化学发光生物传感器标记物的制备方法
EP3236262A3 (en) Surrogate functional diagnostics test for cancer
IN2014CN01787A (enExample)
JP2013522652A5 (enExample)
JP2009540314A5 (enExample)
EP2597617A3 (en) Method and apparatus for displaying ultrasound image
WO2011074802A3 (ko) 전립선암 진단용 키트 및 진단방법
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
Dickinson et al. Single-cell sphingosine kinase activity measurements in primary leukemia
JP2011518338A5 (enExample)
Economos et al. Circulating tumor cells as a marker of response: implications for determining treatment efficacy and evaluating new agents
CN103424402A (zh) 一种体液巯基检测试剂盒
CN203312251U (zh) 一种用于在扫描电镜下观察超薄圆片的样品托装置
RU2017146331A (ru) Способ диагностики рака молочной железы и рака яичников
JP2013513812A5 (enExample)